Skip to main content
. 2014 Jan 14;20(2):414–424. doi: 10.3748/wjg.v20.i2.414

Table 2.

Summary of outcomes post orthotopic liver transplant in hepatitis B virus/human immunodeficiency virus co-infection

Ref. Study period Country n Median follow-up (mo) Survival Graft survival Comments
Coffin et al[49] 2001-2007 United States 22 42 85% 1 yr 85% 1 yr About 50% had detectable HBV pre transplant
85% 3 yr 85% 3 yr
Tateo et al[97] 1999-2007 France 13 32 100% 100% 1 co-infected with HDV, 2 with HCV, 4 with HCV and HDV
Anadol et al[96] 1997-2011 Germany 10 611 90% 1 yr NR
80% 5 yr
Schreibman et al[98] 1999-2006 United States 8 NR 75% 1 yr NR 2 co-infected with HCV, 1 fulminant hepatic failure
75% 3 yr
Norris et al[99] 1995-2003 United Kingdom 4 22 100% 1 yr NR
1

For entire series. HBV: Hepatitis B virus; HCV: Hepatitis C virus; NR: Not reported; HDV: Hepatitis D virus.